Migraine Linked to Increased Risk of IBD in New Study

Health & Lifestyle
279

Listen to article (english)

Translate to Spanish or other 102 languages!

Could migraine increase the risk of inflammatory bowel disease? A new study found a link. Image for illustration purposes
Could migraine increase the risk of inflammatory bowel disease? A new study found a link. Image for illustration purposes

Medical News Today

- Advertisement -
  • More than 1 billion people around the world have at least one migraine attack each year. 
  • Previous research shows that migraine can potentially increase a person’s risk for several health issues, including gastrointestinal conditions.
  • New research from Seoul National University College of Medicine in South Korea says there may also be a link between migraine and an increased risk for inflammatory bowel disease (IBD). 

More than 1 billion peopleTrusted Source globally have at least one migraine attack each year. 

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/migraine-increased-risk-of-ibd-inflammatory-bowel-disease-study?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-01-23&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
What Hispanic People – & Everyone – Should Know About Clinical Trials
Next article
Caffeine Consumption: Some Sources May Surprise You

More Articles

Small Steps in Weight Loss Lead to Big Heart Health Benefits

When people think about weight loss, they often picture dramatic transformations: a major drop on the scale, a new clothing size or a before-and-after photo. But when it comes to overall health, some of the biggest benefits can begin long before those milestone moments.

FDA Approves First Treatment for Certain People With BCG-Unresponsive Bladder Cancer  

The U.S. Food and Drug Administration expanded the approved use of Anktiva (nogapendekin alfa inbakicept-pmln), given with Bacillus Calmette-Guérin (BCG), to include adults with high-grade papillary-only bladder cancer that has not spread into the bladder muscle and has not responded to BCG treatment.

The Power of Proper Handwashing

One simple habit can go a long way toward helping you stay healthy.

Speak Up, Reach Out: STHS Behavioral Tackles Suicide Prevention

Not all wounds are visible. Every day, people struggle with emotional pain, depression and feelings of hopelessness that may go unnoticed by those around them.
- Advertisement -